LINC02196

Across TCGA pan-cancer cohorts, LINC02196 RNA is linked to patient survival in 17 of 34 cancer types, making it the most broadly survival-associated LINC02196 data layer.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where higher LINC02196 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC02196 expression acts as an unfavorable survival marker, although some lineages such as ESCA and ACC show a favorable association.

LIHC, UCEC, and BRCA are the cancer types where LINC02196 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LIHC	OS	Tertile	All	0.375	0.544	.001	54	view →
UCEC	DFS	Tertile	All	0.820	0.909	<.001	42	view →
BRCA	DFS	Tertile	All	0.570	1.000	.033	39	view →
READ	OS	Tertile	All	0.294	0.741	.012	36	view →
KIRP	DFS	Quartile	II,III,IV	0.546	0.836	.002	35	view →
COAD	OS	Tertile	All	0.292	0.604	.001	33	view →
ESCA	DFS	Median	IV	0.634	0.205	.006	30	view →
ACC	DFS	Tertile	All	1.000	0.620	.012	24	view →
LUAD	OS	Tertile	IV	0.481	0.763	.019	18	view →
STAD	OS	Median	IV	0.564	0.192	.004	15	view →
GBM	DFS	Quartile	All	0.156	0.325	.032	9	view →
PAAD	OS	Tertile	All	0.625	0.347	.031	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 17 lineages.

LINC02196–LIHC (OS)

Open the LIHC breakdown →